skip to main content
Idioma:
Mostrar Somente
Refinado por: idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

BOKEMEYER, Carsten ; BONDARENKO, Igor ; LOOS, Anja H ; ZUBEL, Angela ; KORALEWSKI, Piotr ; MAKHSON, Anatoly ; HARTMANN, Joerg T ; APARICIO, Jorge ; DE BRAUD, Filippo ; DONEA, Serban ; LUDWIG, Heinz ; SCHUCH, Gunter ; STROH, Christopher

Journal of clinical oncology, 2009-02, Vol.27 (5), p.663-671 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

SALTZ, Leonard B ; CLARKE, Stephen ; COUTURE, Felix ; SIRZEN, Florin ; CASSIDY, Jim ; DIAZ-RUBIO, Eduardo ; SCHEITHAUER, Werner ; FIGER, Arie ; WONG, Ralph ; KOSKI, Sheryl ; LICHINITSER, Mikhail ; YANG, Tsai-Shen ; RIVERA, Fernando

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2013-2019 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

CASSIDY, Jim ; CLARKE, Stephen ; COUTURE, Felix ; SIRZEN, Florin ; SALTZ, Leonard ; DIAZ-RUBIO, Eduardo ; SCHEITHAUER, Werner ; FIGER, Arie ; WONG, Ralph ; KOSKI, Sheryl ; LICHINITSER, Mikhail ; YANG, Tsai-Shen ; RIVERA, Fernando

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2006-2012 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial

Tabernero, Josep ; Van Cutsem, Eric ; Lakomý, Radek ; Prausová, Jana ; Ruff, Paul ; van Hazel, Guy A ; Moiseyenko, Vladimir M ; Ferry, David R ; McKendrick, Joseph J ; Soussan-Lazard, Karen ; Chevalier, Soazig ; Allegra, Carmen J

European journal of cancer (1990), 2014-01, Vol.50 (2), p.320-331 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial
Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial

Carrato, Alfredo ; Swieboda-Sadlej, Anna ; Staszewska-Skurczynska, Marzanna ; Lim, Robert ; Roman, Laslo ; Shparyk, Yaroslav ; Bondarenko, Igor ; Jonker, Derek J ; Sun, Yan ; De la Cruz, Jhony A ; Williams, J Andrew ; Korytowsky, Beata ; Christensen, James G ; Lin, Xun ; Tursi, Jennifer M ; Lechuga, Maria J ; Van Cutsem, Eric

Journal of clinical oncology, 2013-04, Vol.31 (10), p.1341-1347 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
The role of assessing UGT1A1 gene polymorphism in the prediction of irinotecan-induced toxicity in the course of chemotherapy for colorectal cancer
The role of assessing UGT1A1 gene polymorphism in the prediction of irinotecan-induced toxicity in the course of chemotherapy for colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

The role of assessing UGT1A1 gene polymorphism in the prediction of irinotecan-induced toxicity in the course of chemotherapy for colorectal cancer

Kit, O I ; Vladimirova, L Yu ; Vodolazhskiy, D I ; Abramova, N A ; Dvadnenko, K V

Voprosy onkologij, 2015, Vol.61 (2), p.266-269 [Periódico revisado por pares]

Russia (Federation)

Texto completo disponível

Citações Citado por
7
Biochemical modulation by leucovorin of the antineoplastic effect of fluorofur in disseminated colorectal cancer
Biochemical modulation by leucovorin of the antineoplastic effect of fluorofur in disseminated colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Biochemical modulation by leucovorin of the antineoplastic effect of fluorofur in disseminated colorectal cancer

Manziuk, L V ; Perevodchikova, N I ; Gorbunova, V A ; Luk'ianchenko, A B ; Abramova, N A

Voprosy onkologij, 1996, Vol.42 (3), p.33 [Periódico revisado por pares]

Russia (Federation)

Sem texto completo

Citações Citado por
8
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin

Cassidy, J. ; Twelves, C. ; Van Cutsem, E. ; Hoff, P. ; Bajetta, E. ; Boyer, M. ; Bugat, R. ; Burger, U. ; Garin, A. ; Graeven, U. ; McKendrick, J. ; Maroun, J. ; Marshall, J. ; Osterwalder, B. ; Pérez-Manga, G. ; Rosso, R. ; Rougier, P. ; Schilsky, R. L.

Annals of oncology, 2002-04, Vol.13 (4), p.566-575 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
9
Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial
Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial

TABERNERO, Josep ; GARCIA-CARBONERO, Rocio ; VLADIMIROVA, Liubov ; CHEPOROV, Sergey ; BURDAEVA, Olga ; RIVERA, Fernando ; SAMUEL, Leslie ; BULAVINA, Irina ; POTTER, Vanessa ; CHANG, Yu-Lin ; LOKKER, Nathalie A ; O'DWYER, Peter J ; CASSIDY, James ; SOBRERO, Alberto ; VAN CUTSEM, Eric ; KÖHNE, Claus-Henning ; TEJPAR, Sabine ; GLADKOV, Oleg ; DAVIDENKO, Irina ; SALAZAR, Ramon

Clinical cancer research, 2013-05, Vol.19 (9), p.2541-2550 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
10
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

Cohn, A.L. ; Tabernero, J. ; Maurel, J. ; Nowara, E. ; Sastre, J. ; Chuah, B.Y.S. ; Kopp, M.V. ; Sakaeva, D.D. ; Mitchell, E.P. ; Dubey, S. ; Suzuki, S. ; Hei, Y.-J. ; Galimi, F. ; McCaffery, I. ; Pan, Y. ; Loberg, R. ; Cottrell, S. ; Choo, S.-P.

Annals of oncology, 2013-07, Vol.24 (7), p.1777-1785 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (13)

Idioma 

  1. Inglês  (11)
  2. Japonês  (1)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.